Innovation Pharmaceuticals Inc (IPIX)

[mdphd2008]

The overall mortality rate (6.67%) in the trial was approximately one-half of what is typically observed in this patient population.

In the trial, 120 patients were treated, with three-fourths receiving 5 days of study drug.

To me, that signifies a decrease in mortality!!

Less patients died than normal in the study compared to this very sick group of patients and most were getting Brilacidin!!